Steroid Drug is one of 28 small molecule programs targeting Myasthenia Gravis. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
27 competitors in Myasthenia Gravis
Ultomiris
Vyvgart
Rysodeg
Rituxan
Rayos
Proair HFA
Fabhalta
Blincyto
Actemra
UPLIZNA
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details